Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Minerva patient lift recall

This article was originally published in The Gray Sheet

Executive Summary

Medibo initiates Class I recall of 64 units of the battery-powered patient lifts Aug. 4 due to mechanical problems. Some hanger bars detached because of missing spring washers, causing patients to fall, the agency says. Further Minerva problems cited include loose foot-pedal assembly bolts and faulty actuator brackets on the mast assembly, resulting in lift instability. The recall continues a rising trend in Class I recalls (1"The Gray Sheet" July 19, 2004, p. 16). The Minerva patient lift is technically identical to Arjo's Minstrel, recalled earlier this year...

You may also be interested in...

Zeiss Visulink Reflects Rise In Device Class I Recall Notifications

Carl Zeiss Meditec's Class I voluntary recall is part of a recent uptick in FDA announcements related to the most serious type of device recalls

Pfizer And Moderna Under Pressure To Agree Vaccine Supplies For Developing Nations

As the first emergency use authorization is granted, Pfizer and Moderna stand accused of neglecting poorer nations as wealthy countries snap up early access to COVID-19 vaccines.

FDA Releases Final Guidance For Complex ANDA Meetings

The FDA has released final guidance on “Formal Meetings Between FDA and ANDA Applicants of Complex Products Under GDUFA” for the industry. The guidance brings clarity and aims at facilitating product development meetings between the FDA and the ANDA applicants for complex products.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts